R&D leadership changes at Sucampo

Sucampo Pharmaceuticals has made leadership changes within its research and development (R&D) group after its Senior Vice President stepped down.

Dr Gayle Dolecek has changed to a part-time employee at the company and will now become and Executive Advisor with Dr Peter Lichtlen (pictured) and Taryn R. Joswick sharing the responsibilities.

Chairman, CSO and CEO, Dr Ryuji Ueno, says he is confident that changes “will bring the company’s performance to a new level”.

Currently, Dr Lichtlen works as Senior Medical Officer and Vice President of European Operations, of Sucampo AG and Ms Joswick fulfils the role of Senior Medical Officer and Vice President of European Operations, of Sucampo AG, both subsidiaries of Sucampo.

Dr Lichtlen only joined the company back in July 2011. Ms Joswick joined the company as a research assistant in 2001 and has held the roles of Vice President, Clinical Development, having been named Director, Clinical Development, in 2006.